Company Profile

Emmyon Inc
Profile last edited on: 6/15/21      CAGE: 6S5S9      UEI: M8CMYGLPB5H7

Business Identifier: Chemical compounds to treat skeletal muscle atrophy, obesity, diabetes and fatty liver disease
Year Founded
2012
First Award
2013
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2500 Crosspark Road
Coralville, IA 52241
   (319) 331-2955
   emmyon@emmyon.com
   www.emmyon.com
Location: Single
Congr. District: 02
County: Johnson

Public Profile

Emmyon Inc. is a pharmaceutical research company discovering and developing both natural and chemical compounds that improve muscle mass, strength, exercise capacity, and metabolism. The firm's research has applications in sports nutrition, healthy aging, preventing muscle atrophy, obesity and diabetes, companion animals, and production animals.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Christopher M Adams -- President and Co Founder

  Michael C Dyle -- Research Scientist

  Scott M Ebert -- Senior Research Scientist

  Alok S Shah -- Senior Researcher

  John J Talley -- Senior Scientific Adviser

  Michael Welsh -- Senior Scientific Adviser

Company News

There are no news available.